NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

NCT07211737 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Neuroblastoma
Refractory Neuroblastoma
Relapsed Osteosarcoma
Refractory Osteosarcoma

Interventions

GENETIC: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells
GENETIC: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells
GENETIC: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]